Program Leaders: X. F. Steven Zheng, PhD and Stephen K. Burley, MD, DPhil
 

Overall Goals:

To discover and develop more effective cancer treatments through pharmacology-based preclinical research. The guiding principal is that a fundamental understanding of the biology of molecular targets in cancer is key for discovering and developing innovative therapeutic strategies and for overcoming drug resistance.

Specific Aims:

• To understand the biology of key molecular targets in cancer that drive cell growth, proliferation, and survival so that they can be effectively targeted for cancer therapy.
• To determine the modes of action and mechanisms of resistance to anticancer agents. 
• To discover and develop novel therapeutics and drug delivery technologies for more effective cancer treatment. 

Collaborating Research Programs:

• Cancer Metabolism and Growth
• Genomic Instability and Cancer Genetics
• Clinical Investigations and Precision Therapeutics
• Cancer Prevention and Control

Useful Links:

• CALENDAR: Program Meetings, Lectures and other events for Research Members
• List of Program Members
• Cancer Pharmacology Selected Program-Related Publications